RT Journal Article
SR Electronic
T1 Development and validation of an all-in-one Bat-Clade genomic sequencing and host identification protocol
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.10.31.24316523
DO 10.1101/2024.10.31.24316523
A1 de Souza Godinho, Fernanda Marques
A1 Campos, Aline
A1 Huff, Rosana
A1 Ruivo, Amanda Pellenz
A1 Bermann, Thales
A1 Bauerman, Milena
A1 dos Santos, Franciellen Machado
A1 Selayaran, Taina Machado
A1 Correa, Artur Beineke
A1 dos Santos, Raissa Nunes
A1 Roehe, Paulo Michel
A1 Wallau, Gabriel da Luz
A1 Salvato, Richard Steiner
YR 2024
UL http://medrxiv.org/content/early/2024/11/04/2024.10.31.24316523.abstract
AB Rabies virus (RABV), a fatal zoonotic pathogen, remains a significant public health concern, with bat-maintained lineages accounting for all currently documented cases in Brazil. Despite the availability of pharmacological prophylaxis for humans and animals, the high genetic diversity of RABV in diverse natural bat hosts and continued circulation in multiple animals pose challenges for effective surveillance. Here, we developed and validated a novel, rapidly deployable amplicon-based sequencing approach for rabies virus (RABV) genomic surveillance. This “all-in-one” protocol integrates whole RABV genome sequencing with host species identification through COI gene amplification and sequencing, addressing the challenges posed by RABV’s high genetic diversity and complex transmission dynamics. We assessed the protocol’s effectiveness by sequencing 25 near-complete RABV genomes from host species across four distinct families (Bovidae, Equidae, Felidae, and Microchiroptera) obtained from the Rabies Control and Surveillance Program in Rio Grande do Sul State, Southern Brazil. The method achieved an average genome coverage of 91.4% at a minimum 5x read depth, with a mean depth coverage of 816x across sequenced genomes. The results demonstrated significant Bat-Clade sublineage diversity, which was classified using the MADDOG RABV lineage system. The protocol successfully identified three bat species (Tadarida brasiliensis, Desmodus rotundus, and Myotis nigricans) among the samples, highlighting its capability for precise host identification. This study presents a powerful tool for high-resolution evaluation of RABV genomic features and host identification, enabling more targeted public health interventions. This new approach has the potential to enhance RABV surveillance capabilities, contributing to more effective rabies control strategies within a One Health framework.Competing Interest StatementThe authors have declared no competing interest.Clinical Protocols https://www.protocols.io/view/rabies-virus-bat-clade-sequencing-8epv5x3bng1b/v2 Funding Statement This work was supported by Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS) - FIOCRUZ 13/2022 - REDE SAUDE-RS, grant process 23/2551-0000510-7 and FAPERGS 14/2022 - ARD/ARC, and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ) - grant process 443757/2023-2. CNPQ and FAPERGS do Sul have provided a fellowship to R.S.S (FAPERGS/CNPq 07/2022 - Programa de Apoio a Fixacao de Jovens Doutores no Brasil). G.L.W. is supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) through their productivity research fellowships (307209/2023-7).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe data generated during this study, supplementary material, and all scripts implemented are available at https://github.com/salvatolab/RABV-Bat-clade-sequencing-protocol. https://github.com/salvatolab/RABV-Bat-clade-sequencing-protocol.